Eyal C. Attar
- Hematology top 0.2%
- Molecular Biology top 5%
- Genetics top 0.5%
- Oncology top 5%
- Immunology top 5%
- Co-authors
- Katharine YenLenny DangKaren K. BallenDavid T. ScaddenEdison T. LiuBenjamin L. EbertYih-Woei C. FridellAzra Raza
- Topics
- Acute Myeloid Leukemia Research (56 papers)Hematopoietic Stem Cell Transplantation (27 papers)Chronic Myeloid Leukemia Treatments (18 papers)
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Eyal C. Attar
114 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Hematology 2.3k
- Molecular Biology 2.1k
- Genetics 994
- Oncology 949
- Immunology 843
Countries citing papers authored by Eyal C. Attar
This map shows the geographic impact of Eyal C. Attar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal C. Attar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal C. Attar more than expected).
Fields of papers citing papers by Eyal C. Attar
This network shows the impact of papers produced by Eyal C. Attar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal C. Attar. The network helps show where Eyal C. Attar may publish in the future.
Co-authorship network of co-authors of Eyal C. Attar
This figure shows the co-authorship network connecting the top 25 collaborators of Eyal C. Attar. A scholar is included among the top collaborators of Eyal C. Attar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal C. Attar. Eyal C. Attar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 34 | |
| 3 | 79 | |
| 4 | 22 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | IDH mutations in cancer and progress toward development of targeted therapeuticsbreakdown → | 363 |
| 8 | 2 | |
| 9 | 25 | |
| 10 | 26 | |
| 11 | 100 | |
| 12 | Akt/foxo signaling pathway enforces the differentiation blockade in myeloid leukemias | 1 |
| 13 | 217 | |
| 14 | 7 | |
| 15 | 0 | |
| 16 | 25 | |
| 17 | 26 | |
| 18 | 29 | |
| 19 | 1 | |
| 20 | 30 |
About Eyal C. Attar
Eyal C. Attar is a scholar working on Hematology, Genetics and Oncology, having authored 117 papers that have together received 4.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (56 papers), Hematopoietic Stem Cell Transplantation (27 papers) and Chronic Myeloid Leukemia Treatments (18 papers). The work is most often cited by research in Hematology (2.3k citations), Genetics (994 citations) and Immunology (843 citations). Eyal C. Attar has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Katharine Yen, Lenny Dang, Karen K. Ballen, David T. Scadden, Edison T. Liu, Benjamin L. Ebert, Yih-Woei C. Fridell, Azra Raza, Naomi Galili and David E. Root. Their work appears in journals such as Nature, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.